[ Price : $8.95]
CDER posts its latest guidance agenda that shows it is committing to issuing 11 drug quality guidance documents in 2025.[ Price : $8.95]
An FDA update says contrary to an earlier alert, all new neonatal incubators currently supplied in the U.S. do not show concerning...[ Price : $8.95]
FDA grants AstraZeneca traditional approval for Calquence (acalabrutinib) with bendamustine and rituximab for adults with previous...[ Price : $8.95]
CDRHs annual report says it granted marketing authorization to 120 novel devices in 2024, which was four less than the previous ye...[ Price : $8.95]
FDA sends Atara Biotherapeutics a complete response letter on its BLA for Ebvallo (tabelecleucel), a monotherapy treatment for adu...[ Price : $8.95]
FDA publishes a draft guidance on developing drugs to prevent and treat cancer-related chemotherapy-induced peripheral neuropathy.[ Price : $8.95]
Federal Register notice: FDA seeks public comments on the use of cannabis-derived products (CDPs) in animals.